NEW YORK (GenomeWeb) – Meridian Bioscience issued preliminary fiscal year 2016 earnings after the close of the market on Tuesday, reporting a 1 percent year-over-year increase in revenues.

Meridian expects revenues of $196 million for its fiscal year ending Sept. 30, 2016, including fourth quarter revenues of $47 million. Diluted earnings per share should be in the $.75 to $.76 range for the year, compared to $.85 per share in for FY2015.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.